Bank Julius Baer & Co’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-1,434
| Closed | -$52K | – | 586 |
|
|
2023
Q2 | $52K | Hold |
1,434
| – | – | ﹤0.01% | 496 |
|
|
2023
Q1 | $53K | Sell |
1,434
-60
| -4% | -$2.22K | ﹤0.01% | 513 |
|
|
2022
Q4 | $68K | Sell |
1,494
-9,953
| -87% | -$453K | ﹤0.01% | 498 |
|
|
2022
Q3 | $799K | Buy |
11,447
+8,966
| +361% | +$626K | 0.01% | 285 |
|
|
2022
Q2 | $167K | Buy |
2,481
+730
| +42% | +$49.1K | ﹤0.01% | 427 |
|
|
2022
Q1 | $144K | Buy |
+1,751
| New | +$144K | ﹤0.01% | 460 |
|
|
2021
Q2 | – | Sell |
-3,000
| Closed | -$514K | – | 885 |
|
|
2021
Q1 | $514K | Sell |
3,000
-1,954
| -39% | -$335K | ﹤0.01% | 441 |
|
|
2020
Q4 | $1.09M | Buy |
4,954
+1,954
| +65% | +$429K | 0.01% | 338 |
|
|
2020
Q3 | $498K | Hold |
3,000
| – | – | ﹤0.01% | 387 |
|
|
2020
Q2 | $343K | Sell |
3,000
-2
| -0.1% | -$229 | ﹤0.01% | 401 |
|
|
2020
Q1 | $231K | Buy |
+3,002
| New | +$231K | 0.01% | 385 |
|